News
About 10 million Americans buy individual coverage on or off the marketplaces, get no federal subsidies to help lower cost, feds say.
New law, which takes effect Jan. 1, will address mental health care gaps, particularly in rural areas where recruiting, retaining providers is hard.
Even with an estimated 25 percent premium increase, 78 percent of marketplace consumers should be able to find plan for $100 per month or less.
FDA approved drug Exondys 51 made by Sarepta Therapeutics to treat Duchenne muscular dystrophy.
Massive settlement with DOJ allows EpiPen maker to avoid admitting wrongdoing in how it has classified the emergency allergy treatment since 2007.
Those cared for at higher-cost hospitals have no greater chance of survival, the study found.
Obamacare an issue at ugly, bitter debate, but claims about cost spikes were exaggerated, experts say.
The new CMS model allows insurers to design specific benefits to enrollees with a combination of chronic conditions.
Group sent a letter to CMS requesting transparent processes for dealing with MIPS, a shorter reporting period and lower thresholds for MIPS exclusions.
Deal will be funded with available cash, and is due to close by first quarter 2017, company says.